CME Institute Activities

Additional stories

European and American regulators found no evidence linking GLP-1 receptor agonists like Ozempic and Wegovy to thoughts of suicide.
The FDA has issued consumer warnings regarding certain over-the-counter topical pain relievers.
This week, we expose racial differences in postpartum mood disorders, explore cannabis use and birth defects, and tardive dyskinesia.
A new study suggests that more extreme global temperatures might be responsible for climbing stroke rates.
Understanding the link between Type D personality and hypothyroidism can enhance patient care and treatment satisfaction.
A new study has revealed a connection between a family history of TRD and increased risks of suicide mortality and resistance to treatment.
Research reveals the frustrating link between antipsychotics and metabolic functions, highlighting the importance of monitoring and cautious prescribing practices.
Amylyx Pharmaceuticals Inc. says it’s pulling Relyvrio from the U.S. and Canadian markets, effective immediately.
This week, we expose racial differences in postpartum mood disorders, explore cannabis use and birth defects, and tardive dyskinesia.